Houston, United States
AiCure, with its slogan "Predictive Insights. Personalized Care.", stands as a prominent figure in the integration of AI and advanced data analytics within the healthcare and clinical trials sectors. Founded in 2010 and headquartered in the United States, the company leverages technology to monitor patient behavior, improving study predictability and reducing associated costs.
AiCure’s innovative solutions focus on remote engagement in clinical trials, emphasizing digital biomarkers and real-time patient dosing monitoring. The company's efforts are bolstered by over 84 issued patents and collaborations with clients across more than 46 countries. Recognized with accolades like the Scrip Award, AI 100, and Digital Health 150, AiCure demonstrates impactful industry leadership.
Recently, AiCure secured a $12.00M Debt Financing on January 23, 2024, reflecting continued investor confidence in its strategic vision and operational capabilities. This positions AiCure as a compelling opportunity for investors interested in AI-driven healthcare innovation.
Rely Health